Survival analysis of 306 European Spanish patients with systemic lupus erythematosus

被引:57
作者
Blanco, FJ
Gomez-Reino, JJ
de la Mata, J
Corrales, A
Rodriguez-Valverde, V
Rosas, JC
de la Camara, AG
Pascual, E
机构
[1] Hosp 12 Octubre, E-28041 Madrid, Spain
[2] Hosp Marques Valdecilla, Santander, Spain
[3] Hosp Gen Alicante, Alicante, Spain
关键词
systemic lupus erythematosus; survival in lupus; predictors of mortality; causes of death; Caucasian south European lupus;
D O I
10.1191/096120398678919930
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To describe survival of lupus in South European Spanish patients. Patients and Methods: Observational study of all SLE Spanish patients seen at three University Hospitals between 1975 and 1993. The charts of all patients were retrospectively reviewed. Sixty-four clinic and laboratory variables were extracted from charts. Univariate analysis, multivariate Cox proportional hazard regression analysis, actuarial life tables and multiple logistic regression analysis were used to calculate survival probability and identify variables associated with survival. Results: Three hundred and six (275 female and 31 male) patients were identified. Their mean age at diagnosis was 31.9 years (range 4 to 85). The mean duration of followup was 79 (1-126) months. Thirty-one patients died. The most common cause of death was infection (29%). Five, 10 and 15 years' survival rate was 90% +/- 0.0158, 85% +/- 0.0262 and 80% +/- 0.0413, respectively. Log-rank analysis showed that male sex, proteinuria and nephropathy at diagnosis were associated with poor survival. By univariate and multivariate analysis male gender, nephropathy and CNS involvement were associated with worse survival. Conclusion: In SLE patients from Spain, rate of survival is similar to other Caucasian patients, and better than other ethnic groups of Spanish ancestry. Other factors rather than genetic factors could explain our findings.
引用
收藏
页码:159 / 163
页数:5
相关论文
共 41 条
  • [1] ABUSHAKRA M, 1995, J RHEUMATOL, V22, P1259
  • [2] ABUSHAKRA M, 1995, J RHEUMATOL, V22, P1265
  • [3] ALARCON G S, 1986, Boletin de la Oficina Sanitaria Panamericana, V101, P309
  • [4] SYSTEMIC LUPUS-ERYTHEMATOSUS IN AUSTRALIAN ABORIGINES - HIGH PREVALENCE, MORBIDITY AND MORTALITY
    ANSTEY, NM
    BASTIAN, I
    DUNCKLEY, H
    CURRIE, BJ
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1993, 23 (06): : 646 - 651
  • [5] BLANCO FJ, 1994, BRIT J RHEUMATOL, V33, P260
  • [6] DUBOIS EL, 1974, JAMA-J AM MED ASSOC, V227, P1399
  • [7] THE RELATIONSHIP OF SOCIOECONOMIC-STATUS TO SUBSEQUENT HEALTH-STATUS IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    ESDAILE, JM
    SAMPALIS, JS
    LACAILLE, D
    DANOFF, D
    [J]. ARTHRITIS AND RHEUMATISM, 1988, 31 (03): : 423 - 427
  • [8] Fernandez RN, 1992, REV BRASIL REUMATOL, V32, P41
  • [9] ADVANCES IN MANAGEMENT OF RHEUMATIC DISEASE - 1965 TO 1985
    FRIES, JF
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1989, 149 (05) : 1002 - 1011
  • [10] GINZLER E, 1987, J RHEUMATOL, V14, P218